Merck & Co., Inc. (MRK) operating KPIs
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)
Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%
Merck acquisitions of Businesses, Net of Cash Acquired ($M) ($M)
Postgres DB financial_values
Latest, Q2 2026
0
Period ended Jun 30, 2026
Change on a year earlier
–
0 in Q2 2025
History
58 quarters
Since Q1 2009
Sources
43
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Acquisitions of Businesses, Net of Cash Acquired ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 0 | – | Form 10-Q (filed 2026-08-07) ↗ |
| Q1 2026 | Mar 31, 2026 | -8,779 | – | Form 10-Q (filed 2026-05-04) ↗ |
| Q4 2025 | Dec 31, 2025 | -10,042 | -847.2% | Form 10-K (filed 2026-02-24) ↗ |
| Q3 2025 | Sep 30, 2025 | 0 | -100.0% | Form 10-Q (filed 2025-11-05) ↗ |
| Q2 2025 | Jun 30, 2025 | 0 | – | Form 10-Q (filed 2025-08-05) ↗ |
| Q1 2025 | Mar 31, 2025 | 0 | -100.0% | Form 10-Q (filed 2025-05-02) ↗ |
| Q4 2024 | Dec 31, 2024 | 1,344 | – | Form 10-K (filed 2026-02-24) ↗ |
| Q3 2024 | Sep 30, 2024 | -598 | – | Form 10-Q (filed 2025-11-05) ↗ |
| Q2 2024 | Jun 30, 2024 | 0 | – | Form 10-Q (filed 2024-08-05) ↗ |
| Q1 2024 | Mar 31, 2024 | -746 | – | Form 10-Q (filed 2024-05-03) ↗ |
| Q4 2023 | Dec 31, 2023 | 0 | -100.0% | Form 10-K (filed 2024-02-26) ↗ |
| Q3 2023 | Sep 30, 2023 | 0 | -100.0% | Form 10-Q (filed 2024-08-05) ↗ |
| Q2 2023 | Jun 30, 2023 | 0 | – | Form 10-Q (filed 2024-08-05) ↗ |
| Q1 2023 | Mar 31, 2023 | 0 | – | Form 10-Q (filed 2024-05-03) ↗ |
| Q4 2022 | Dec 31, 2022 | 121 | -234.4% | Form 10-K (filed 2025-02-25) ↗ |
| Q3 2022 | Sep 30, 2022 | -121 | -12,200.0% | Form 10-Q (filed 2022-11-03) ↗ |
| Q4 2021 | Dec 31, 2021 | -90 | -80.3% | Form 10-K (filed 2022-02-25) ↗ |
| Q3 2021 | Sep 30, 2021 | 1 | -100.2% | Form 10-Q (filed 2021-11-05) ↗ |
| Q2 2021 | Jun 30, 2021 | -76 | -76.3% | Form 10-Q (filed 2021-08-09) ↗ |
| Q1 2021 | Mar 31, 2021 | -14 | – | Form 10-Q (filed 2021-05-05) ↗ |
| Q4 2020 | Dec 31, 2020 | -458 | +1,732.0% | Form 10-K (filed 2021-02-25) ↗ |
| Q3 2020 | Sep 30, 2020 | -586 | -58,700.0% | Form 10-Q (filed 2020-11-05) ↗ |
| Q2 2020 | Jun 30, 2020 | -321 | +18.9% | Form 10-Q (filed 2021-05-05) ↗ |
| Q1 2020 | Mar 31, 2020 | 0 | – | Form 10-Q (filed 2021-05-05) ↗ |
| Q4 2019 | Dec 31, 2019 | -25 | -57.6% | Form 10-K (filed 2020-02-26) ↗ |
| Q3 2019 | Sep 30, 2019 | 1 | – | Form 10-Q (filed 2019-11-05) ↗ |
| Q2 2019 | Jun 30, 2019 | -270 | -27.4% | Form 10-Q (filed 2020-05-06) ↗ |
| Q1 2019 | Mar 31, 2019 | 0 | – | Form 10-Q (filed 2020-05-06) ↗ |
| Q4 2018 | Dec 31, 2018 | -59 | +20.4% | Form 10-K (filed 2019-02-27) ↗ |
| Q3 2018 | Sep 30, 2018 | 0 | – | Form 10-Q (filed 2018-11-06) ↗ |
| Q2 2018 | Jun 30, 2018 | -372 | +807.3% | Form 10-Q (filed 2018-08-07) ↗ |
| Q1 2018 | Mar 31, 2018 | 0 | -100.0% | Form 10-Q (filed 2018-05-08) ↗ |
| Q4 2017 | Dec 31, 2017 | -49 | +2,350.0% | Form 10-K (filed 2018-02-27) ↗ |
| Q3 2017 | Sep 30, 2017 | 0 | -100.0% | SEC Filing ↗ |
| Q2 2017 | Jun 30, 2017 | -41 | +310.0% | SEC Filing ↗ |
| Q1 2017 | Mar 31, 2017 | -306 | +108.2% | SEC Filing ↗ |
| Q4 2016 | Dec 31, 2016 | -2 | -94.4% | SEC Filing ↗ |
| Q3 2016 | Sep 30, 2016 | -621 | +464.5% | SEC Filing ↗ |
| Q2 2016 | Jun 30, 2016 | -10 | – | SEC Filing ↗ |
| Q1 2016 | Mar 31, 2016 | -147 | – | SEC Filing ↗ |
| Q4 2015 | Dec 31, 2015 | -36 | -80.1% | Form 10-K (filed 2016-02-26) ↗ |
| Q3 2015 | Sep 30, 2015 | -110 | – | SEC Filing ↗ |
| Q2 2015 | Jun 30, 2015 | 0 | – | SEC Filing ↗ |
| Q1 2015 | Mar 31, 2015 | 0 | – | SEC Filing ↗ |
| Q4 2014 | Dec 31, 2014 | -181 | – | Form 10-Q (filed 2015-11-05) ↗ |
| Q3 2014 | Sep 30, 2014 | 0 | – | Form 10-Q (filed 2015-11-05) ↗ |
| Q2 2014 | Jun 30, 2014 | 0 | – | Form 10-Q (filed 2015-08-06) ↗ |
| Q1 2014 | Mar 31, 2014 | 0 | – | Form 10-Q (filed 2015-05-07) ↗ |
| Q4 2011 | Dec 31, 2011 | 0 | -100.0% | Form 10-K (filed 2012-02-28) ↗ |
| Q3 2011 | Sep 30, 2011 | 0 | -100.0% | Form 10-Q (filed 2011-11-08) ↗ |
| Q4 2010 | Dec 31, 2010 | -104 | – | Form 10-Q (filed 2011-11-08) ↗ |
| Q3 2010 | Sep 30, 2010 | -11 | – | Form 10-Q (filed 2011-11-08) ↗ |
| Q2 2010 | Jun 30, 2010 | -10 | – | Form 10-Q (filed 2011-08-08) ↗ |
| Q1 2010 | Mar 31, 2010 | -131 | +0.8% | Form 10-Q (filed 2011-05-09) ↗ |
| Q4 2009 | Dec 31, 2009 | 0 | – | Form 10-Q (filed 2010-11-08) ↗ |
| Q3 2009 | Sep 30, 2009 | 0 | – | Form 10-Q (filed 2010-11-08) ↗ |
| Q2 2009 | Jun 30, 2009 | 0 | – | Form 10-Q (filed 2010-08-06) ↗ |
| Q1 2009 | Mar 31, 2009 | -130 | – | Form 10-Q (filed 2010-05-07) ↗ |
Cite this data
StockData. (2026). Merck Acquisitions of Businesses, Net of Cash Acquired ($M) ($M), quarterly Q1 2009–Q2 2026 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/db_cf_acq
See every metric in the Merck KPI table. Data updated Oct 26, 2026.